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Abstract Rare disruptions of FOXP2 have been strongly
implicated in deficits in language development. Research
over the past decade has suggested a role in the formation
of underlying neural circuits required for speech. Until
recently no evidence existed to suggest that the closely
related FOXP1 gene played a role in neurodevelopmental
processes. However, in the last few years, novel rare dis-
ruptions in FOXP1 have been reported in multiple cases of
cognitive dysfunction, including intellectual disability and
autism spectrum disorder, together with language impair-
ment. As FOXP1 and FOXP2 form heterodimers for tran-
scriptional regulation, one may assume that they co-operate
in common neurodevelopmental pathways through the co-
regulation of common targets. Here we compare the phe-
notypic consequences of FOXP1 and FOXP2 impairment,
drawing on well-known studies from the past as well as
recent exciting findings and consider what these tell us
regarding the functions of these two genes in neural
development.
Introduction
Forkhead box (FOX) proteins are an evolutionarily ancient
family of transcription factors characterised by a highly
conserved forkhead DNA-binding domain. Despite the
similarity in the DNA-binding domain, FOX proteins have
a wide range of important biological functions (Hannenh-
alli and Kaestner 2009). Most FOX proteins bind to their
target DNA sequences as monomers, except members of
the FOXP subfamily, which includes FOXP1–4. FOXP
proteins are somewhat atypical as they also possess a zinc
finger and leucine zipper domain, both of which mediate
interactions with other proteins, thus allowing FOXP pro-
teins to form homo- and heterodimers to facilitate their
binding to DNA for transcriptional regulation (Li et al.
2004). In the past, members of the FOXP subfamily have
been implicated in various human diseases (Bennett and
Ochs 2001; Jin et al. 2010; Lai et al. 2001), but only
FOXP1 and FOXP2 have been linked to cognitive disor-
ders so far.
Perhaps the most prominent of the FOXP genes is
FOXP2 (OMIM 605317), whose involvement in speech
and language acquisition has now been studied for more
than 10 years (Fisher and Scharff 2009). FOXP2 and lan-
guage development has generated extreme interest as the
acquisition of spoken language is central to what makes us
human. In the last 2 years, evidence has emerged that
implicates FOXP1 (OMIM 605515), the closest relative of
FOXP2 (64 % total protein sequence identity, 89 % in the
forkhead domain), in the pathology of human cognitive
disorders, which involve language impairment. FOXP1 and
FOXP2 are already known to co-operate in the regulation
of non-neural developmental processes (Shu et al. 2007)
and it will be interesting to validate whether this co-oper-
ation extends to brain development. A comparison of the
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clinical phenotypes caused by FOXP1 and FOXP2 dis-
ruption would provide important steps towards uncovering
those regions of neuropathology in which these genes play
a role.
FOXP2 mutations are implicated in developmental
verbal dyspraxia
Foxp2 contributes to lung, heart and oesophagus develop-
ment (Shu et al. 2001, 2007), but the most well-known role
of this gene is in the development of speech and language
(Fisher and Scharff 2009; Newbury and Monaco 2010).
Human FOXP2 was first linked to language development
in 2001, when a heterozygous missense mutation in the
forkhead domain (R553H) was found to be causative for an
inherited language disorder in a large 3-generation pedi-
gree known as the KE family (Lai et al. 2001). The KE
family has been extensively studied and the phenotype is
now well defined, affecting expressive, receptive and
written language (Table 1). A core feature of the disorder is
a difficulty in the learning and production of co-ordinated
sequences of orofacial movements, which impairs the
production of fluent speech (Vargha-Khadem et al. 1995;
Watkins et al. 2002a). Therefore the affected members
have a primary diagnosis of developmental verbal dys-
praxia (DVD), which is also known as childhood apraxia of
speech (CAS). Studies on the KE family have also included
formal evaluations of non-verbal intelligence and the
average IQ of affected KE family members is lower than
that of unaffected individuals (Fisher et al. 1998; Vargha-
Khadem et al. 1995; Watkins et al. 2002a), raising the
possibility that the missense mutation in the FOXP2 gene
also impacts other cognitive functions. Nevertheless, the
most prominent and consistent features of the disorder are
in the domain of speech and language, with more severe
and wide-ranging effects on verbal skills than on non-
verbal cognition (Watkins et al. 2002a).
The presence of just one de novo mutation within the
coding region of FOXP2 did not, by itself, provide com-
pelling evidence that FOXP2 contributes to the pathology of
DVD. To assess the contribution of heterozygous FOXP2
mutations in patient samples independent from the KE
family, FOXP2 was screened in 49 unrelated children
diagnosed with DVD (MacDermot et al. 2005). Three dif-
ferent variants altering the FOXP2 protein sequence in three
individual patients were identified. The most interesting of
these variants was a heterozygous nonsense mutation (not
found in 252 controls) which yielded a stop codon at position
328 of the FOXP2 protein, resulting in either a truncated
protein missing the functionally important forkhead, leucine
zipper and zinc finger domains or a complete loss of FOXP2
due to nonsense mediated RNA decay. The child had a
diagnosis of DVD and displayed articulation problems along
with impaired receptive and expressive language develop-
ment. The same mutation was also detected in an affected
sibling as well as the mother, who was reported to have a
history of speech difficulties. This finding offered further
evidence that FOXP2 is of pathological importance in DVD
in the absence of other cognitive disorders, which were
exclusion criteria in this study.
Various large-scale 7q31 deletions that include the
FOXP2 gene, ranging from 1.57 Mb to 15 Mb in size, have
also been reported in patients with DVD (Feuk et al. 2006;
Lennon et al. 2007; Palka et al. 2012; Rice et al. 2011;
Zeesman et al. 2006; Zilina et al. 2011). DVD was reported
in every case and most of the reports concluded that
impaired language was due to the loss of FOXP2. How-
ever, the large size of these deletions encompassing several
to many genes is a complication for understanding the links
between phenotypes and FOXP2 dysfunction. Transloca-
tion breakpoints directly disrupting the FOXP2 locus in
patients diagnosed with DVD provided more clear-cut
support for the relevance of this gene to speech and lan-
guage pathology (Table 1) (Feuk et al. 2006; Lai et al.
2000, 2001; Shriberg et al. 2006; Tomblin et al. 2009).
The reported FOXP2 variants are rare but have not been
found in normal individuals from the 1,000 genome project
and taken together, three translocation breakpoints dis-
rupting FOXP2 (Feuk et al. 2006; Lai et al. 2000; Shriberg
et al. 2006), one missense mutation (Lai et al. 2001) and
one nonsense mutation (MacDermot et al. 2005) indepen-
dently associated with a DVD phenotype provide strong
genetic evidence for the role of FOXP2 in the clinical
phenotype (summarised in Table 1).
Evidence for a role of FOXP1 in neurodevelopmental
disorders
Foxp1 has been associated with a wide range of functions
including development of the lung, heart, oesophagus,
immune system and spinal motor neurons, as well as cancer
(Banham et al. 2001; Dasen et al. 2008; Hu et al. 2006; Jepsen
et al. 2008; Palmesino et al. 2010; Rousso et al. 2008; Shi
et al. 2004; Shu et al. 2001, 2007; Wang et al. 2004). It has
been known for some time that Foxp1 is expressed in par-
ticular neuronal subpopulations in the developing brain
(Ferland et al. 2003), but its precise roles in brain develop-
ment have not been defined. Given that the expression of
Foxp1 and Foxp2 overlaps in certain areas of the developing
brain (Ferland et al. 2003; Teramitsu et al. 2004) and that
Foxp1 and Foxp2 are able to form heterodimers for tran-
scriptional repression (Li et al. 2004), it is reasonable to
hypothesize that FOXP1 could also be involved in the
pathology of DVD. However, in a screen of the entire coding
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Table 1 Summary of clinical phenotypes of patients reported with heterozygous intragenic mutations, deletions and disruptions of FOXP2 (in
chronological order)
References FOXP2 variant IQ Clinical information
Vargha-Khadem et al.
(1995, 1998)a
R553H (KE) 86 affected, 104
unaffected
Impaired speech production. Grammar defects. Impaired
orofacial praxis. Articulatory impairment. Abnormal
activation in motor-related areas during word repetition
(PET). Caudate nucleus is structurally abnormal and smaller
in affected members (MRI)





R553H (KE) 83; affected (2),
98; unaffected (3)
Expressive, receptive and written language impaired. Impaired
articulation is core deficit
Affected members had reduced volume and significantly less
grey matter bilaterally in the caudate nucleus (voxel-based
morphometry of MRI)
Liegeois et al. (2003)a R553H (KE) NR Abnormal activation of Broca’s area and putamen (fMRI)
MacDermot et al.
(2005)a
R328X NR DVD. Repetitive and expressive language scores 3 SD below
mean. Problems with articulation. Affected sibling also
carried variant
Q17L NR DVD. Affected sibling did not carry variant
Insertion leading to an
expansion of the
polyglutamine tract
NR DVD. Affected sibling did not carry variant
Lai et al. (2000)b t(5;7) (q22;q31.2) balanced
translocation
NR Language impairment. DVD. Mild delay in mental
development at 3.5 years
Shriberg et al. (2006)
Tomblin et al. (2009)b
t(7;13) (q31.1;q13.2)
balanced translocation
95 and 87 Both mother and daughter have spastic dysarthia and DVD.
Expressive and receptive language and grammatical ability
impaired
Feuk et al. 2006)b t (3;7) (q23;q31.2)
translocation
NR DVD
Feuk et al. (2006)c Five 7q31 dels: 3 9 15 Mb,
13 Mb and 11 Mb
3 patients below
average
All five patients had DVD as well as speech delay and an
articulation disorder. Two patients had general
developmental delay. One patient was reported to have ASD,
another to be ‘ASD-like’
Zeesman et al. (2006)c Del 7q31.2–q32.2 Female patient. DVD. Cognitive abilities ranged from below
average to average. Did not meet criteria for autism
Lennon et al. (2007)c 9.1 Mb del 7q31.2–7q31.31 Female patient. DVD. Moderate intellectual disability. Did not
meet criteria for autism
Zilina et al. (2011)c *8.3 Mb del
7q31.1–q31.31.,
inherited from mother
88 Female patient. Moderate developmental delay. Poor
vocabulary. Orofacial motor defects. Some autistic features.
Affected mother has speech delay and DVD
6.5 Mb del 7q31.1–q31.2.,
inherited from mother
NR Developmental delay in all areas. Mild ataxia. Pronunciation
difficulties and poor vocabulary. Affected mother has
intellectual disability, DVD and mood disorder





Male patient. DVD. Mother’s early verbal development similar
to the patient’s
Palka et al. (2012)c 14.8 Mb mosaic del 71 Female patient. DVD. Developmental delay. Normal brain
MRI. Mild psychomotor retardation. Severe language delay.
Impaired receptive, expressive, comprehensive and written
language
All IQ scores are non-verbal
DVD developmental verbal dyspraxia, ASD autism spectrum disorder, NR not reported
a Rows represent intragenic mutations leading to amino acid changes and insertions
b Rows represent translocations
c Rows represent deletions
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region of FOXP1 in 49 DVD patients, (the identical cohort
used in the FOXP2 screening described earlier), no poten-
tially disease-causing variants were found (Vernes et al.
2009). Although the patient cohort was small, it suggested
that, unlike FOXP2, mutations in FOXP1 are not sufficient to
cause DVD in isolation. Instead, various screening studies
carried out within the last few years have revealed that
FOXP1 may be of more global importance in a range of
neurodevelopmental disorders, which includes but is not
restricted to speech and language disorders.
The first hint that FOXP1 may be involved in neuro-
developmental disorders was provided by a heterozygous
deletion in 3p14.1, which affected FOXP1, EIF4E3,
PROK2 and GPR27, in a patient with speech delay,
hypertonia and additional phenotypes (for details see
Table 2) (Pariani et al. 2009). The authors optimistically
attributed many of the patient’s symptoms including the
speech delay to the disruption of FOXP1, but the contri-
bution of PROK2 and GPR27 to the phenotype cannot be
ruled out, especially considering that both genes were
Table 2 Summary of clinical phenotypes of patients reported with heterozygous disruptions in FOXP1 (in chronological order)
Reference FOXP1 variant IQ Clinical information
Pariani et al. (2009)a 785 kb del (FOXP1, EIF4E3,
PROK2 and GPR27)
NR Male patient. Gross motor delay. Contractures. Blephharophimosis
Hypertonia. Speech delay; vowel sounds but no words at 23 months
Carr et al. (2010)a *1.0 Mb del NR Male patient. Gross motor delay. Chiari I malformation, dysmorphic but
intact corpus callosum and mild hypoplasia of the cerebellar vermis
(MRI). Speech delay, difficulty producing multisyllabic speech, limited
verbal output. Effective use of sign language to compensate problems
with verbal expression. No deficits in oromotor co-ordination
Horn et al. (2010)a 498 kb del (all but first coding
exon)
\50 Male patient. Gross motor delay. Speech delay; first words at 3.5 years,
combined words at 7 years. Expressive language more affected than
receptive language. Articulation problems and poor grammar. No brain
abnormalities (MRI, EEG)
659 kb del (entire coding region) \50 Female patient. Gross motor delay. Speech delay; first vocalising at
4 months, first words at 3.5 years, combined words at 5 years.
Expressive language more affected than receptive language.
Articulation problems and poor grammar. No brain abnormalities (MRI,
EEG)
1,047 kb del (entire coding region) 50 Male patient. Gross motor delay. Speech delay – first vocalising at
12 months, first words at 3.5 years, combined words at 5.5 years.
Expressive language more affected than receptive language.
Articulation problems and poor grammar. No brain abnormalities (MRI,
EEG)
Hamdan et al. (2010) *390 kb del (exons 4–14 of
FOXP1a)a
58 Female patient. Global developmental delay. Severe language
impairment, expressive language of 4.5 years at 15 years of age.
Receptive language more developed. No deficits in oromotor co-
ordination reported. Autistic features but below threshold for autism
diagnosis. Aberrant behaviours with social withdrawal, anxiety,
aggression, irritability
R525Xb 48 Male patient. Global developmental delay. ASD. Severe language
impairment; expressive language of 1 year 11 months at 9 years of age.
Performed at age 3 years 7 months in auditory comprehension tasks. No
defecits in oromotor co-ordination reported. Aberrant behaviours with
irritability, hyperactivity, stereotypy, obsessions and compulsions, self-
injurious behaviour
O’Roak et al. (2011)b p.Ala339SerfsX4 34 Male patient. Language (phrases) delay. ASD. Aberrant behaviours
include lethargy, hyperactivity, inappropriate speech
Talkowski et al. (2012)c t(3;10) (p13;q21.2) balanced
translocation
NR Global developmental delay. Speech delay. Bilateral inguinal hernia.
Spina bifida oculta. Dysmorphic features
All IQ measurements are non-verba
NR not reported, ASD autism spectrum disorder
a Rows represent deletions
b Rows represent intragenic mutations
c Row represents a translocation
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previously implicated in developmental retardation (Petek
et al. 2003). More convincing evidence was provided when
a deletion exclusively affecting the FOXP1 gene was found
in a male child with impaired language acquisition and
motor development delay (Carr et al. 2010). Unfortunately,
a confounding factor in this study was the presence of a
Chiari I malformation (cerebellar tonsil abnormality) in the
patient, which may have contributed to the delay in motor
and speech development, therefore convincing evidence for
a role of FOXP1 in cognitive disorders was still lacking.
Shortly afterwards, a large-scale screen for copy number
variations (CNVs) in 1,523 patients with intellectual dis-
ability, uncovered three de novo heterozygous deletions
solely affecting FOXP1 (Horn et al. 2010). A large 1.3 Mb
deletion affecting FOXP1 and other genes was also found
in a control individual (Horn et al. 2010). The three patients
had moderate intellectual disability (IQ of \50), gross
motor delay and a severe speech and language defect,
characterised by a delay in the onset of speech, dysgram-
matism and very poor speech articulation. Two of the
reported patients also had an oromotor defect, including
difficulties with lip protrusion and tongue elevation, but
DVD was not diagnosed. These findings provided the first
compelling evidence that disruptions in the FOXP1 gene
can be causative for multiple neurodevelopmental abnor-
malities, which include language impairment, implicating
FOXP1 in more widespread cognitive processes than were
previously described for FOXP2. This hypothesis gained
further support from a recent independent study of 110
individuals with intellectual disability and/or autism spec-
trum disorder (ASD), which identified a de novo intragenic
FOXP1 deletion in a patient with both intellectual dis-
ability (IQ of 58) and severe language impairment, par-
ticularly affecting expressive language (Hamdan et al.
2010). The deletion included sequences corresponding to the
leucine zipper and zinc finger domains, which are important
for FOXP1 dimerization and transcriptional repression. In
addition to the deletion, a de novo nonsense mutation,
R525X, was found in the FOXP1 forkhead domain in
another patient with non-syndromic intellectual disability
(IQ of 48), severe language impairment and ASD. This
study added further weight to previous findings that FOXP1
is important for language development and normal intelli-
gence and the discovery of a FOXP1 stop mutation in a
patient with ASD was exciting, as it highlighted FOXP1 for
the first time as a potential ASD candidate gene.
Whole exome sequencing has the potential to identify
all coding variants in an affected individual and was
recently used to define rare de novo coding mutations in 20
individuals with ASD and their healthy parents, along with
20 unrelated ethnically matched controls (O’Roak et al.
2011). Among several presumably causative mutations in
different genes was a single base insertion in FOXP1,
introducing a frameshift and premature stop codon
(A339SfsX4). This individual had severe ASD and delayed
language development together with intellectual disability
(IQ of 34), reminiscent of previously reported FOXP1
phenotypes (Carr et al. 2010; Hamdan et al. 2010; Horn
et al. 2010). An additional inherited missense variant,
H275R, was also detected in the CNTNAP2 gene. As
CNTNAP2 has been implicated in intellectual disability
(Gregor et al. 2011; Zweier et al. 2009), ASD (Alarcon
et al. 2008) and in language impairment without ASD
(Vernes et al. 2008; Whitehouse et al. 2012), it could also
have contributed to the patient’s phenotype. As FOXP1
was found to regulate CNTNAP2 expression, the FOXP1
mutant identified in this patient could enhance any poten-
tially damaging effects of the CNTNAP2 H275R variant,
highlighting the presence of putative modifier gene effects
(O’Roak et al. 2011).
Very recently, direct sequencing of balanced chromo-
somal breakpoints in 38 patients with ASD uncovered a
translocation breakpoint affecting FOXP1 on chromosome
3p and ANK3 on chromosome 10q in an individual with
ASD and speech delay (Talkowski et al. 2012). While
ANK3 has previously been implicated in bipolar disorder
and schizophrenia (Ferreira et al. 2008; Williams et al.
2011), secondary CNV analysis of FOXP1 and ANK3 in
19,566 patients with ASD revealed a significant CNV
burden for FOXP1, but not ANK3 (Talkowski et al. 2012).
The distinct but complementary approaches of chromo-
somal breakpoint sequencing followed by an extensive
secondary assessment of CNV findings provided further
compelling support that FOXP1 represents a gene with a
widespread role in neurodevelopmental processes.
Taken together, five FOXP1 single gene deletions (Carr
et al. 2010; Hamdan et al. 2010; Horn et al. 2010), two
intragenic nonsense and frameshift mutations (Hamdan
et al. 2010; O’Roak et al. 2011) and a chromosomal
breakpoint disrupting FOXP1 supported by secondary
CNV analysis (Talkowski et al. 2012) in patients with
intellectual disability, ASD, language disorder and motor
development delay, provide strong evidence for FOXP1
underlying various cognitive phenotypes (summarised in
Table 2).
Similarities and differences between phenotypes
associated with FOXP1 and FOXP2 disruptions
Language disorder
In language disorders, a distinction is often made as to
whether the language impairments are primarily receptive
(hearing, reading and comprehending) or expressive
(speaking and writing), or affect both. People with FOXP2
Hum Genet (2012) 131:1687–1698 1691
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mutations have both impaired expressive and receptive
language (MacDermot et al. 2005; Watkins et al. 2002a),
whereas expressive language appears to be more affected
in patients with FOXP1 disruptions (Hamdan et al. 2010;
Horn et al. 2010). A core feature of the phenotype asso-
ciated with FOXP2 dysfunction is an abnormal articulation
due to verbal dyspraxia, i.e. impairment in the motor pro-
gramming of orofacial movements required to produce
normal speech (MacDermot et al. 2005; Vargha-Khadem
et al. 1995). Although articulation problems have been
described in some patients with FOXP1 disruption (Horn
et al. 2010), orofacial dyspraxia has not been diagnosed so
far (Carr et al. 2010; Hamdan et al. 2010; Horn et al. 2010;
O’Roak et al. 2011), neither have any FOXP1 variants been
identified in the small DVD patient cohort (Vernes et al.
2009). As FOXP1 variants are yet to be associated solely
with a language disorder without additional cognitive
phenotypes, the possibility exists that the language disorder
observed in patients with disruptions in FOXP1 is a con-
sequence of more global cognitive disruption rather than a
specific disruption in those neural circuits necessary for
speech production. This could be elucidated by compara-
tive brain imaging of patients with FOXP1 and FOXP2
disruptions as well as comparing behavioural, electro-
physiological and morphological phenotypes of Foxp1 and
Foxp2 knockout mice. Generally, a delay in language
acquisition is often observed in ASD individuals along with
significantly impaired comprehension, articulation and
grammar, which improves with time (Boucher 2011).
Similarly, language deficits are often severe in children
diagnosed with intellectual disability (Kaufman et al.
2010). Thus, the impaired language observed in patients
with FOXP1 disruptions could be a secondary consequence
of these disorders. In summary, there is an overlap in the
language phenotype of patients with disruptions in FOXP1
and FOXP2, particularly regarding expressive language
impairment (Fig. 1), but how similar the mechanistic basis
is remains unclear.
Autism spectrum disorder
Autism spectrum disorder is characterised by impaired
social interaction and communication, language impair-
ment and the presence of restrictive and repetitive behav-
iours. In most cases, ASD is inherited and the specific
genetic disruptions are known in only a minority of cases
(Geschwind 2011). ASD has been diagnosed in patients
with various disruptions in the FOXP1 gene (Hamdan et al.
2010; O’Roak et al. 2011; Talkowski et al. 2012), impli-
cating FOXP1 in the pathology of ASD. Chromosome
7q31 is a known autism susceptibility locus, particularly
involving the language impairment of the disorder (Alar-
con et al. 2002), therefore FOXP2 has been suggested as a
potential ASD candidate gene. However, FOXP2 screen-
ings in different cohorts of ASD patients have failed to
identify any causative mutations (Gauthier et al. 2003;
Newbury et al. 2002; Wassink et al. 2002). Yet, in a recent
large-scale haplotype mapping analysis FOXP2 was iden-
tified as a novel ASD candidate gene, among 1,218 others
(Casey et al. 2011). FOXP2 is also implicated in the etio-
logical pathways of ASD through its target genes MET
(Mukamel et al. 2011) and CNTNAP2 (Vernes et al. 2008),
although CNTNAP2 has also been linked to language
impairment where there is no diagnosis of ASD (Vernes
et al. 2008). Additionally, people with isolated mutations of
FOXP2 do not show any signs of ASD even though FOXP2
is involved in pathways relevant to autism. Thus, while the
possibility is open that screening studies of FOXP2 in
larger cohorts of ASD patients could identify causative
FOXP2 variants in the future, existing evidence suggests
that—in contrast to FOXP1—FOXP2 is not involved in
ASD.
Intellectual disability
Intellectual disability is a cognitive disorder characterised
by an IQ of\70 (Kaufman et al. 2010). All non-verbal IQs
reported in patients with FOXP1 variants are below this
threshold (Table 2) indicating that intellectual disability is
a consistent feature of the phenotype associated with
FOXP1 disruption. Most but not all affected KE family
members with FOXP2 missense mutations have a lower IQ
than unaffected members (Fisher et al. 1998, 2003; Var-
gha-Khadem et al. 1995; Watkins et al. 2002a) but normal
IQs have been reported in other patients with perturbations
in the FOXP2 gene (MacDermot et al. 2005; Tomblin et al.
2009). Intellectual disability therefore cannot be considered
a reliable characteristic of the phenotype associated with
FOXP2 disruption at this time. The reported IQs of patients
Fig. 1 Summary of similarities and differences between FOXP1 and
FOXP2 neuronal phenotypes
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with FOXP1 disruptions are much lower than those
reported for people with FOXP2 variants (Tables 1, 2);
therefore intelligence appears to be influenced more
strongly by FOXP1 than FOXP2 dysfunction.
Motor development delay
Although difficulties with fine motor movement and co-
ordination are sometimes present in DVD patients with
FOXP2 mutations, gross motor and developmental delay
appear to be more predominant in patients with FOXP1
disruption (Tables 1, 2). The delayed motor development
described in most human patients with disruptions in the
FOXP1 gene (Carr et al. 2010; Hamdan et al. 2010; Horn
et al. 2010; Pariani et al. 2009) is interesting, as Foxp1
defines the identity of motor neurons in the mouse spinal
cord and influences motor neuron migration, axon projec-
tion and axonal branching at muscle targets (Dasen et al.
2008; Palmesino et al. 2010; Rousso et al. 2008). Therefore
the delayed motor development in individuals with FOXP1
disruptions may be influenced by pathologies in both the
central and peripheral nervous system.
Steps towards elucidating neurodevelopmental
pathways influenced by FOXP1 and FOXP2
Disruptions of FOXP1 and FOXP2 cause distinct pheno-
types with some overlapping features (Fig. 1), pointing to
both shared and distinct neurodevelopmental roles for these
two genes. Below we discuss potential approaches to elu-
cidate the molecular pathways and circuits involved.
Defining the neural phenotype of patients
The neural basis of behavioural abnormalities can be
identified by structural and functional brain imaging of
patients. MRI analyses of some FOXP1 patients have been
performed but have revealed no obvious structural brain
abnormalities (Carr et al. 2010; Horn et al. 2010). Con-
ventional neuroradiological assessment of MRI scans
performed on affected members of the KE family also
revealed no obvious abnormalities at first (Vargha-Khadem
et al. 2005), but application of voxel-based morphometry,
which can detect more subtle differences in grey and white
matter and additional volumetric analysis revealed signif-
icant differences in specific brain regions of affected KE
members (Watkins et al. 2002b). The neuroanatomical
effects of the KE mutation have been extensively reviewed
elsewhere (Vargha-Khadem et al. 2005), but in brief
involve abnormalities in the cortex, cerebellum and basal
ganglia, particularly the striatum (Liegeois et al. 2003;
Vargha-Khadem et al. 1998; Watkins et al. 2002b). These
findings from brain imaging implicate FOXP2 in the
development of cortico-striatal circuits, which are involved
in sensorimotor integration required for vocal motor
learning. This would suggest that the phenotype observed
in the KE family stems from disruption in the underlying
neural circuits of language development, an idea that has
received support from animal studies (see below).
Animal studies
Studies using animal models have taken us a long way
towards elucidating the role of Foxp2 in brain develop-
ment. Several Foxp2 knockout and mutant mouse models
have been generated and the different phenotypes have
already been extensively reviewed (Fisher and Scharff
2009). In brief, these phenotypes include developmental
delay, motor impairment, cerebellar abnormalities and
disrupted synaptic plasticity in the striatum. Recently, it
was further demonstrated that motor skill learning is sig-
nificantly impaired in mice carrying the equivalent muta-
tion to that found in affected KE family members, which
was explained by aberrant striatal activity during motor
skill learning (French et al. 2011).
Two amino acid substitutions in the human FOXP2
protein have emerged during human evolution, possibly
linked to the development of speech and language (Enard
et al. 2002) and a partially humanised form of the FOXP2
gene has been shown to increase synaptic plasticity in the
striatum of mice (Enard et al. 2009). This phenotype is
Fig. 2 Summary of different FOXP1 (below) and FOXP2 (above)
mutations decribed. See Tables 1 and 2 for reference details. Variant
S339AfsX4 was identified by whole exome sequencing and an
additional missense variant in the CNTNAP2 gene was also present in
this individual
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opposite to what has been described in mice with Foxp2
dysfunction (French et al. 2011; Groszer et al. 2008) sug-
gesting that the emergence of human FOXP2 may have
enhanced cortico-striatal circuits or circuit properties dur-
ing the evolution of spoken language. Taken together, these
animal studies have revealed that Foxp2 is involved in the
development of neural plasticity in circuits contributing to
language and a possibly wider cognitive function, which is
in agreement with the findings from neuroimaging of KE
family members (see above) (Fig. 2).
Foxp1 knockout mouse models have been used to
investigate the importance of Foxp1 in a range of non-
neural developmental processes (Feng et al. 2010; Hu et al.
2006; Shu et al. 2007; Wang et al. 2004; Wu et al. 2006)
and in the development of motor neurons in the spinal cord
(Dasen et al. 2008), but have not been used to define the
role of Foxp1 in brain development. Homozygous loss of
Foxp1 causes embryonic death at E14.5 due to heart failure
(Wang et al. 2004). Conditional removal of Foxp1 in the
brain will therefore be the key to elucidating the impor-
tance of Foxp1 during later stages of brain development. It
will be interesting to see whether brain-related aspects of
the Foxp1 knockout phenotype are distinct from the Foxp2
knockout phenotype, as is the case in the human situation.
Foxp1 and Foxp2 expression overlaps in the striatum,
thalamus, superior colliculus and inferior olive in the
mature mouse brain, but their expression differs in other
regions including the cortex, hippocampus and inferior
colliculus (Ferland et al. 2003). It is interesting that his-
tological analyses of brains from Foxp2 knockout mice
only revealed gross morphological abnormalities in the
cerebellum, where Foxp1 is not co-expressed (French et al.
2007), suggesting that Foxp1 may compensate for the loss
of Foxp2 and that a level of redundancy exists between
these two genes. It will be interesting to see whether layers
3, 4 and 5 of the cortex or the hippocampus which express
Foxp1 only are exclusively abnormal in the Foxp1
knockout mouse.
Identification of target genes
Common FOXP1 and FOXP2 neurodevelopmental path-
ways seem likely, considering their potential to form het-
erodimers and their co-expression in certain brain tissues.
On the other hand, the distinct phenotypes seen in patients
with FOXP1 and FOXP2 disruption would suggest they
participate at least to some degree, in independent path-
ways. The identification and classification of target genes
hold the key to determining which pathways and networks
involve FOXP1 and FOXP2 during brain development. For
FOXP2, genome wide in vivo ChIP-chip screens coupled
to expression profiling have already been used to define
transcriptional targets in the developing brain; many of
these targets were found to be involved in pathways reg-
ulating neurite outgrowth, axon guidance and synaptic
plasticity (Konopka et al. 2009; Spiteri et al. 2007; Vernes
et al. 2007, 2011). Elsewhere, it has been shown that
FOXP2 directly regulates CNTNAP2, mutations in which,
like FOXP2, were found to be linked to language impair-
ment (Vernes et al. 2008), the autism candidate gene MET,
involved in neuronal differentiation (Mukamel et al. 2011)
as well as the schizophrenia susceptibility gene Disrupted
in schizophrenia 1 (DISC1) in HEK293 cells (76). Whether
the identification of DISC1 as a FOXP2 target places
FOXP2 in schizophrenia-related pathways remains unclear.
There is conflicting evidence for a role of FOXP2 in
schizophrenia; significant associations have been reported
between certain FOXP2 SNPs and schizophrenia (Sanjuan
et al. 2006; Tolosa et al. 2010), but the FOXP2 missense
and nonsense mutations associated with DVD (Table 1)
were not found in patients with schizophrenia (Sanjuan
et al. 2005). In conclusion, the published targets of FOXP2
implicate this transcription factor in pathways regulating
neurite outgrowth, axon guidance and synaptic plasticity,
which is in agreement with a role of FOXP2 in the
development of neural circuits for language development.
The genes regulated by FOXP1 in developing brain
tissue have not yet been identified by genome-wide ChIP
screens. Overexpression of Foxp1 in a murine striatal cell
line has recently revealed a repression of immune-related
genes (Tang et al. 2012), which is in agreement with pre-
vious studies demonstrating a role of Foxp1 in immune
development. Given the level of cognitive disruption caused
by FOXP1 variants, it is reasonable to assume that FOXP1
targets will be uncovered in many neurodevelopmental
pathways and not limited to immune function. There is
evidence that CNTNAP2 expression is regulated by FOXP1
(O’Roak et al. 2011), which has also been shown for
FOXP2 (Vernes et al. 2008), providing the first evidence
for a common FOXP1–FOXP2 pathway involving CNT-
NAP2 in neurodevelopmental processes. On the other
hand, the fact that CNTNAP2 is implicated in both ASD
(Alarcon et al. 2008) and in language impairment without
ASD (Vernes et al. 2008) suggests distinct CNTNAP2
pathways exist. Elsewhere, Foxp1 has also been shown to
regulate Pitx3 transcription during the differentiation of ES
cells into midbrain dopaminergic neurons (Konstantoulas
et al. 2010).
Typically, transcription factors do not act alone but
rather in complexes together with other transcription fac-
tors, chromatin remodellers and cofactor proteins to bind to
promoter sequences and regulate target gene expression.
FOXP1 and FOXP2 interact with various proteins to reg-
ulate gene expression in different tissues (supplementary
Table 1) (Chokas et al. 2010; Datta et al. 2008; Jepsen
et al. 2008; Li et al. 2004; Otaegi et al. 2011; Ravasi et al.
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2010; Takayama et al. 2008; Wu et al. 2006; Zhou et al.
2008) but identification of the combinatorial interactions of
FOXP1 and FOXP2 with other proteins specifically in the
brain will be needed to understand the roles they play in
brain development. The interactions of FOXP1 and FOXP2
with different proteins represent another dimension to the
regulation of their target genes.
Concluding remarks
Disease-causing variants in both FOXP1 and FOXP2 are
relatively rare, but play a significant role in the pathology
of cognitive diseases. While the importance of FOXP2 in
the pathology of DVD has been a popular topic of inves-
tigation for more than 10 years, it remains to be seen
whether perturbations in FOXP2 are confined to language
impairment or whether there is also some risk for other
diagnostic entities. Genetic evidence emerging in the last
2 years provides compelling evidence that FOXP1 variants
are responsible for a more global cognitive phenotype,
encompassing language impairment, intellectual disability,
ASD and motor development delay. The phenotypic
spectra of FOXP1 and FOXP2 disruptions suggest that
these two closely related transcription factors are involved
in both shared and distinct neurodevelopmental pathways
underlying cognitive diseases through the regulation of
common and exclusive targets. The findings discussed in
this review show that FOXP1 and FOXP2 may provide
crucial insight into the molecular pathways involved in
human cognitive diseases.
Acknowledgments We thank Simon E. Fisher and Ute Moog for
valuable comments.
Conflict of interest The authors declare that they have no conflict
of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
Alarcon M, Cantor RM, Liu J, Gilliam TC, Geschwind DH (2002)
Evidence for a language quantitative trait locus on chromosome
7q in multiplex autism families. Am J Hum Genet 70:60–71
Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar
JM, Sebat J, Wigler M, Martin CL, Ledbetter DH, Nelson SF,
Cantor RM, Geschwind DH (2008) Linkage, association, and
gene-expression analyses identify CNTNAP2 as an autism-
susceptibility gene. Am J Hum Genet 82:150–159
Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K,
Jones M, Mason DY, Prime JE, Trougouboff P, Wood K, Cordell
JL (2001) The FOXP1 winged helix transcription factor is a
novel candidate tumor suppressor gene on chromosome 3p.
Cancer Res 61:8820–8829
Bennett CL, Ochs HD (2001) IPEX is a unique X-linked syndrome
characterized by immune dysfunction, polyendocrinopathy,
enteropathy, and a variety of autoimmune phenomena. Curr
Opin Pediatr 13:533–538
Boucher J (2011) Research review: structural language in autistic
spectrum disorder—characteristics and causes. J Child Psychol
Psychiatry
Carr CW, Moreno-De-Luca D, Parker C, Zimmerman HH, Ledbetter
N, Martin CL, Dobyns WB, Abdul-Rahman OA (2010) Chiari I
malformation, delayed gross motor skills, severe speech delay,
and epileptiform discharges in a child with FOXP1 haploinsuf-
ficiency. Eur J Hum Genet 18:1216–1220
Casey JP, Magalhaes T, Conroy JM, Regan R, Shah N, Anney R,
Shields DC, Abrahams BS, Almeida J, Bacchelli E, Bailey AJ,
Baird G, Battaglia A, Berney T, Bolshakova N, Bolton PF,
Bourgeron T, Brennan S, Cali P, Correia C, Corsello C,
Coutanche M, Dawson G, de Jonge M, Delorme R, Duketis E,
Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Foley S,
Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT,
Green J, Guter SJ, Hakonarson H, Holt R, Hughes G, Hus V,
Igliozzi R, Kim C, Klauck SM, Kolevzon A, Lamb JA, Leboyer
M, Le Couteur A, Leventhal BL, Lord C, Lund SC, Maestrini E,
Mantoulan C, Marshall CR, McConachie H, McDougle CJ,
McGrath J, McMahon WM, Merikangas A, Miller J, Minopoli F,
Mirza GK, Munson J, Nelson SF, Nygren G, Oliveira G,
Pagnamenta AT, Papanikolaou K, Parr JR, Parrini B, Pickles A,
Pinto D, Piven J, Posey DJ, Poustka A, Poustka F, Ragoussis J,
Roge B, Rutter ML, Sequeira AF, Soorya L, Sousa I, Sykes N,
Stoppioni V, Tancredi R, Tauber M, Thompson AP, Thomson S,
Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Vorstman
JA, Wallace S, Wang K, Wassink TH, White K, Wing K, et al
(2011) A novel approach of homozygous haplotype sharing
identifies candidate genes in autism spectrum disorder. Hum
Genet
Chokas AL, Trivedi CM, Lu MM, Tucker PW, Li S, Epstein JA,
Morrisey EE (2010) Foxp1/2/4-NuRD interactions regulate gene
expression and epithelial injury response in the lung via
regulation of interleukin-6. J Biol Chem 285:13304–13313
Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM (2008) Hox
repertoires for motor neuron diversity and connectivity gated by
a single accessory factor, FoxP1. Cell 134:304–316
Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu
CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST
(2008) Methylation mediated silencing of MicroRNA-1 gene and
its role in hepatocellular carcinogenesis. Cancer Res 68:
5049–5058
Enard W, Przeworski M, Fisher SE, Lai CS, Wiebe V, Kitano T,
Monaco AP, Paabo S (2002) Molecular evolution of FOXP2, a
gene involved in speech and language. Nature 418:869–872
Enard W, Gehre S, Hammerschmidt K, Holter SM, Blass T, Somel M,
Bruckner MK, Schreiweis C, Winter C, Sohr R, Becker L, Wiebe
V, Nickel B, Giger T, Muller U, Groszer M, Adler T, Aguilar A,
Bolle I, Calzada-Wack J, Dalke C, Ehrhardt N, Favor J, Fuchs H,
Gailus-Durner V, Hans W, Holzlwimmer G, Javaheri A,
Kalaydjiev S, Kallnik M, Kling E, Kunder S, Mossbrugger I,
Naton B, Racz I, Rathkolb B, Rozman J, Schrewe A, Busch DH,
Graw J, Ivandic B, Klingenspor M, Klopstock T, Ollert M,
Quintanilla-Martinez L, Schulz H, Wolf E, Wurst W, Zimmer A,
Fisher SE, Morgenstern R, Arendt T, de Angelis MH, Fischer J,
Schwarz J, Paabo S (2009) A humanized version of Foxp2
affects cortico-basal ganglia circuits in mice. Cell 137:961–971
Feng X, Ippolito GC, Tian L, Wiehagen K, Oh S, Sambandam A,
Willen J, Bunte RM, Maika SD, Harriss JV, Caton AJ,
Hum Genet (2012) 131:1687–1698 1695
123
Bhandoola A, Tucker PW, Hu H (2010) Foxp1 is an essential
transcriptional regulator for the generation of quiescent naive T
cells during thymocyte development. Blood 115:510–518
Ferland RJ, Cherry TJ, Preware PO, Morrisey EE, Walsh CA (2003)
Characterization of Foxp2 and Foxp1 mRNA and protein in the
developing and mature brain. J Comp Neurol 460:266–279
Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM,
Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW,
Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML,
Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS,
Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C,
Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin
A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ,
MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC,
Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH,
Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick
EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood
DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N
(2008) Collaborative genome-wide association analysis supports
a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet
40:1056–1058
Feuk L, Kalervo A, Lipsanen-Nyman M, Skaug J, Nakabayashi K,
Finucane B, Hartung D, Innes M, Kerem B, Nowaczyk MJ,
Rivlin J, Roberts W, Senman L, Summers A, Szatmari P, Wong
V, Vincent JB, Zeesman S, Osborne LR, Cardy JO, Kere J,
Scherer SW, Hannula-Jouppi K (2006) Absence of a paternally
inherited FOXP2 gene in developmental verbal dyspraxia. Am J
Hum Genet 79:965–972
Fisher SE, Scharff C (2009) FOXP2 as a molecular window into
speech and language. Trends Genet 25:166–177
Fisher SE, Vargha-Khadem F, Watkins KE, Monaco AP, Pembrey
ME (1998) Localisation of a gene implicated in a severe speech
and language disorder. Nat Genet 18:168–170
Fisher SE, Lai CS, Monaco AP (2003) Deciphering the genetic basis
of speech and language disorders. Annu Rev Neurosci 26:57–80
French CA, Groszer M, Preece C, Coupe AM, Rajewsky K, Fisher SE
(2007) Generation of mice with a conditional Foxp2 null allele.
Genesis 45:440–446
French CA, Jin X, Campbell TG, Gerfen E, Groszer M, Fisher SE,
Costa RM (2011) An aetiological Foxp2 mutation causes
aberrant striatal activity and alters plasticity during skill
learning. Mol Psychiatry
Gauthier J, Joober R, Mottron L, Laurent S, Fuchs M, De Kimpe V,
Rouleau GA (2003) Mutation screening of FOXP2 in individuals
diagnosed with autistic disorder. Am J Med Genet A
118A:172–175
Geschwind DH (2011) Genetics of autism spectrum disorders. Trends
Cogn Sci 15:409–416
Gregor A, Albrecht B, Bader I, Bijlsma EK, Ekici AB, Engels H,
Hackmann K, Horn D, Hoyer J, Klapecki J, Kohlhase J,
Maystadt I, Nagl S, Prott E, Tinschert S, Ullmann R, Wohlleber
E, Woods G, Reis A, Rauch A, Zweier C (2011) Expanding the
clinical spectrum associated with defects in CNTNAP2 and
NRXN1. BMC Med Genet 12:106
Groszer M, Keays DA, Deacon RM, de Bono JP, Prasad-Mulcare S, Gaub
S, Baum MG, French CA, Nicod J, Coventry JA, Enard W, Fray M,
Brown SD, Nolan PM, Paabo S, Channon KM, Costa RM, Eilers J,
Ehret G, Rawlins JN, Fisher SE (2008) Impaired synaptic plasticity
and motor learning in mice with a point mutation implicated in
human speech deficits. Curr Biol 18:354–362
Hamdan FF, Daoud H, Rochefort D, Piton A, Gauthier J, Langlois M,
Foomani G, Dobrzeniecka S, Krebs MO, Joober R, Lafreniere
RG, Lacaille JC, Mottron L, Drapeau P, Beauchamp MH,
Phillips MS, Fombonne E, Rouleau GA, Michaud JL (2010) De
novo mutations in FOXP1 in cases with intellectual disability,
autism, and language impairment. Am J Hum Genet 87:671–678
Hannenhalli S, Kaestner KH (2009) The evolution of Fox genes and
their role in development and disease. Nat Rev Genet
10:233–240
Horn D, Kapeller J, Rivera-Brugues N, Moog U, Lorenz-Depiereux
B, Eck S, Hempel M, Wagenstaller J, Gawthrope A, Monaco AP,
Bonin M, Riess O, Wohlleber E, Illig T, Bezzina CR, Franke A,
Spranger S, Villavicencio-Lorini P, Seifert W, Rosenfeld J,
Klopocki E, Rappold GA, Strom TM (2010) Identification of
FOXP1 deletions in three unrelated patients with mental
retardation and significant speech and language deficits. Hum
Mutat 31:E1851–E1860
Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW,
Rao A (2006) Foxp1 is an essential transcriptional regulator of B
cell development. Nat Immunol 7:819–826
Jepsen K, Gleiberman AS, Shi C, Simon DI, Rosenfeld MG (2008)
Cooperative regulation in development by SMRT and FOXP1.
Genes Dev 22:740–745
Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K,
Holland PJ, Bennett DC, Wallace MR, McCormack WT, Kemp
EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taieb
A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A,
Spritz RA (2010) Common variants in FOXP1 are associated
with generalized vitiligo. Nat Genet 42:576–578
Kaufman L, Ayub M, Vincent JB (2010) The genetic basis of non-
syndromic intellectual disability: a review. J Neurodev Disord
2:182–209
Konopka G, Bomar JM, Winden K, Coppola G, Jonsson ZO, Gao F,
Peng S, Preuss TM, Wohlschlegel JA, Geschwind DH (2009)
Human-specific transcriptional regulation of CNS development
genes by FOXP2. Nature 462:213–217
Konstantoulas CJ, Parmar M, Li M (2010) FoxP1 promotes midbrain
identity in embryonic stem cell-derived dopamine neurons by
regulating Pitx3. J Neurochem 113:836–847
Lai CS, Fisher SE, Hurst JA, Levy ER, Hodgson S, Fox M, Jeremiah
S, Povey S, Jamison DC, Green ED, Vargha-Khadem F, Monaco
AP (2000) The SPCH1 region on human 7q31: genomic
characterization of the critical interval and localization of
translocations associated with speech and language disorder.
Am J Hum Genet 67:357–368
Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP (2001)
A forkhead-domain gene is mutated in a severe speech and
language disorder. Nature 413:519–523
Lennon PA, Cooper ML, Peiffer DA, Gunderson KL, Patel A, Peters
S, Cheung SW, Bacino CA (2007) Deletion of 7q31.1 supports
involvement of FOXP2 in language impairment: clinical report
and review. Am J Med Genet A 143A:791–798
Li S, Weidenfeld J, Morrisey EE (2004) Transcriptional and DNA
binding activity of the Foxp1/2/4 family is modulated by
heterotypic and homotypic protein interactions. Mol Cell Biol
24:809–822
Liegeois F, Baldeweg T, Connelly A, Gadian DG, Mishkin M,
Vargha-Khadem F (2003) Language fMRI abnormalities asso-
ciated with FOXP2 gene mutation. Nat Neurosci 6:1230–1237
MacDermot KD, Bonora E, Sykes N, Coupe AM, Lai CS, Vernes SC,
Vargha-Khadem F, McKenzie F, Smith RL, Monaco AP, Fisher
SE (2005) Identification of FOXP2 truncation as a novel cause of
developmental speech and language deficits. Am J Hum Genet
76:1074–1080
Mukamel Z, Konopka G, Wexler E, Osborn GE, Dong H, Bergman
MY, Levitt P, Geschwind DH (2011) Regulation of MET by
FOXP2, genes implicated in higher cognitive dysfunction and
autism risk. J Neurosci 31:11437–11442
Newbury DF, Monaco AP (2010) Genetic advances in the study of
speech and language disorders. Neuron 68:309–320
Newbury DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G,
Jannoun L, Slonims V, Stott CM, Merricks MJ, Bolton PF,
1696 Hum Genet (2012) 131:1687–1698
123
Bailey AJ, Monaco AP (2002) FOXP2 is not a major suscep-
tibility gene for autism or specific language impairment. Am J
Hum Genet 70:1318–1327
O’Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S,
Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ,
Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE
(2011) Exome sequencing in sporadic autism spectrum disorders
identifies severe de novo mutations. Nat Genet 43:585–589
Otaegi G, Pollock A, Hong J, Sun T (2011) MicroRNA miR-9
modifies motor neuron columns by a tuning regulation of FoxP1
levels in developing spinal cords. J Neurosci 31:809–818
Palka C, Alfonsi M, Mohn A, Cerbo R, Franchi PG, Fantasia D,
Morizio E, Stuppia L, Calabrese G, Zori R, Chiarelli F, Palka G
(2012) Mosaic 7q31 deletion involving FOXP2 gene associated
with language impairment. Pediatrics 129:e183–e188
Palmesino E, Rousso DL, Kao TJ, Klar A, Laufer E, Uemura O,
Okamoto H, Novitch BG, Kania A (2010) Foxp1 and lhx1
coordinate motor neuron migration with axon trajectory choice
by gating Reelin signalling. PLoS Biol 8:e1000446
Pariani MJ, Spencer A, Graham JM Jr, Rimoin DL (2009) A 785 kb
deletion of 3p14.1p13, including the FOXP1 gene, associated
with speech delay, contractures, hypertonia and blepharophimo-
sis. Eur J Med Genet 52:123–127
Petek E, Windpassinger C, Simma B, Mueller T, Wagner K, Kroisel
PM (2003) Molecular characterisation of a 15 Mb constitutional
de novo interstitial deletion of chromosome 3p in a boy with
developmental delay and congenital anomalies. J Hum Genet
48:283–287
Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K,
Akalin A, Schmeier S, Kanamori-Katayama M, Bertin N,
Carninci P, Daub CO, Forrest AR, Gough J, Grimmond S, Han
JH, Hashimoto T, Hide W, Hofmann O, Kamburov A, Kaur M,
Kawaji H, Kubosaki A, Lassmann T, van Nimwegen E,
MacPherson CR, Ogawa C, Radovanovic A, Schwartz A,
Teasdale RD, Tegner J, Lenhard B, Teichmann SA, Arakawa
T, Ninomiya N, Murakami K, Tagami M, Fukuda S, Imamura K,
Kai C, Ishihara R, Kitazume Y, Kawai J, Hume DA, Ideker T,
Hayashizaki Y (2010) An atlas of combinatorial transcriptional
regulation in mouse and man. Cell 140:744–752
Rice GM, Raca G, Jakielski KJ, Laffin JJ, Iyama-Kurtycz CM,
Hartley SL, Sprague RE, Heintzelman AT, Shriberg LD (2011)
Phenotype of FOXP2 haploinsufficiency in a mother and son.
Am J Med Genet A
Rousso DL, Gaber ZB, Wellik D, Morrisey EE, Novitch BG (2008)
Coordinated actions of the forkhead protein Foxp1 and Hox
proteins in the columnar organization of spinal motor neurons.
Neuron 59:226–240
Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Molto MD, Najera C,
de Frutos R (2005) FOXP2 polymorphisms in patients with
schizophrenia. Schizophr Res 73:253–256
Sanjuan J, Tolosa A, Gonzalez JC, Aguilar EJ, Perez-Tur J, Najera C,
Molto MD, de Frutos R (2006) Association between FOXP2
polymorphisms and schizophrenia with auditory hallucinations.
Psychiatr Genet 16:67–72
Shi C, Zhang X, Chen Z, Sulaiman K, Feinberg MW, Ballantyne CM,
Jain MK, Simon DI (2004) Integrin engagement regulates
monocyte differentiation through the forkhead transcription
factor Foxp1. J Clin Invest 114:408–418
Shriberg LD, Ballard KJ, Tomblin JB, Duffy JR, Odell KH, Williams
CA (2006) Speech, prosody, and voice characteristics of a
mother and daughter with a 7;13 translocation affecting FOXP2.
J Speech Lang Hear Res 49:500–525
Shu W, Yang H, Zhang L, Lu MM, Morrisey EE (2001) Character-
ization of a new subfamily of winged-helix/forkhead (Fox) genes
that are expressed in the lung and act as transcriptional
repressors. J Biol Chem 276:27488–27497
Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D, Morrisey EE (2007)
Foxp2 and Foxp1 cooperatively regulate lung and esophagus
development. Development 134:1991–2000
Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, Vernes
SC, Fisher SE, Ren B, Geschwind DH (2007) Identification of
the transcriptional targets of FOXP2, a gene linked to speech and
language, in developing human brain. Am J Hum Genet
81:1144–1157
Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K,
Hayashizaki Y, Ouchi Y, Inoue S (2008) FOXP1 is an androgen-
responsive transcription factor that negatively regulates andro-
gen receptor signaling in prostate cancer cells. Biochem Biophys
Res Commun 374:388–393
Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang
C, Heilbut A, Ernst C, Hanscom C, Rossin E, Lindgren AM,
Pereira S, Ruderfer D, Kirby A, Ripke S, Harris DJ, Lee JH, Ha
K, Kim HG, Solomon BD, Gropman AL, Lucente D, Sims K,
Ohsumi TK, Borowsky ML, Loranger S, Quade B, Lage K,
Miles J, Wu BL, Shen Y, Neale B, Shaffer LG, Daly MJ, Morton
CC, Gusella JF (2012) Sequencing chromosomal abnormalities
reveals neurodevelopmental loci that confer risk across diag-
nostic boundaries. Cell 149:525–537
Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM, Connolly C,
Masliah E, Leavitt BR, Thomas EA (2012) Forkhead box protein
p1 is a transcriptional repressor of immune signaling in the CNS:
implications for transcriptional dysregulation in Huntington
disease. Hum Mol Genet
Teramitsu I, Kudo LC, London SE, Geschwind DH, White SA (2004)
Parallel FoxP1 and FoxP2 expression in songbird and human
brain predicts functional interaction. J Neurosci 24:3152–3163
Tolosa A, Sanjuan J, Dagnall AM, Molto MD, Herrero N, de Frutos R
(2010) FOXP2 gene and language impairment in schizophrenia:
association and epigenetic studies. BMC Med Genet 11:114
Tomblin JB, O’Brien M, Shriberg LD, Williams C, Murray J, Patil S,
Bjork J, Anderson S, Ballard K (2009) Language features in a
mother and daughter of a chromosome 7;13 translocation
involving FOXP2. J Speech Lang Hear Res 52:1157–1174
Vargha-Khadem F, Watkins K, Alcock K, Fletcher P, Passingham R
(1995) Praxic and nonverbal cognitive deficits in a large family
with a genetically transmitted speech and language disorder.
Proc Natl Acad Sci USA 92:930–933
Vargha-Khadem F, Watkins KE, Price CJ, Ashburner J, Alcock KJ,
Connelly A, Frackowiak RS, Friston KJ, Pembrey ME, Mishkin
M, Gadian DG, Passingham RE (1998) Neural basis of an
inherited speech and language disorder. Proc Natl Acad Sci USA
95:12695–12700
Vargha-Khadem F, Gadian DG, Copp A, Mishkin M (2005) FOXP2
and the neuroanatomy of speech and language. Nat Rev Neurosci
6:131–138
Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE,
Geschwind DH, Fisher SE (2007) High-throughput analysis of
promoter occupancy reveals direct neural targets of FOXP2, a
gene mutated in speech and language disorders. Am J Hum
Genet 81:1232–1250
Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J,
Groszer M, Alarcon M, Oliver PL, Davies KE, Geschwind DH,
Monaco AP, Fisher SE (2008) A functional genetic link between
distinct developmental language disorders. N Engl J Med
359:2337–2345
Vernes SC, MacDermot KD, Monaco AP, Fisher SE (2009) Assessing
the impact of FOXP1 mutations on developmental verbal
dyspraxia. Eur J Hum Genet 17:1354–1358
Vernes SC, Oliver PL, Spiteri E, Lockstone HE, Puliyadi R, Taylor
JM, Ho J, Mombereau C, Brewer A, Lowy E, Nicod J, Groszer
M, Baban D, Sahgal N, Cazier JB, Ragoussis J, Davies KE,
Geschwind DH, Fisher SE (2011) Foxp2 regulates gene
Hum Genet (2012) 131:1687–1698 1697
123
networks implicated in neurite outgrowth in the developing
brain. PLoS Genet 7:e1002145
Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE,
Tucker PW (2004) Foxp1 regulates cardiac outflow tract,
endocardial cushion morphogenesis and myocyte proliferation
and maturation. Development 131:4477–4487
Wassink TH, Piven J, Vieland VJ, Pietila J, Goedken RJ, Folstein SE,
Sheffield VC (2002) Evaluation of FOXP2 as an autism
susceptibility gene. Am J Med Genet 114:566–569
Watkins KE, Dronkers NF, Vargha-Khadem F (2002a) Behavioural
analysis of an inherited speech and language disorder: compar-
ison with acquired aphasia. Brain 125:452–464
Watkins KE, Vargha-Khadem F, Ashburner J, Passingham RE,
Connelly A, Friston KJ, Frackowiak RS, Mishkin M,
Gadian DG (2002b) MRI analysis of an inherited speech
and language disorder: structural brain abnormalities. Brain
125:465–478
Whitehouse AJ, Bishop DV, Ang QW, Pennell CE, Fisher SE (2012)
CNTNAP2 variants affect early language development in the
general population. Genes Brain Behav 11:501
Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V,
Dwyer S, Smith RL, Green E, Grozeva D, Holmans P, Owen MJ,
O’Donovan MC (2011) Most genome-wide significant suscep-
tibility loci for schizophrenia and bipolar disorder reported to
date cross-traditional diagnostic boundaries. Hum Mol Genet
20:387–391
Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC,
Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen
L, Rao A (2006) FOXP3 controls regulatory T cell function
through cooperation with NFAT. Cell 126:375–387
Zeesman S, Nowaczyk MJ, Teshima I, Roberts W, Cardy JO, Brian J,
Senman L, Feuk L, Osborne LR, Scherer SW (2006) Speech and
language impairment and oromotor dyspraxia due to deletion of
7q31 that involves FOXP2. Am J Med Genet A 140:509–514
Zhou B, Zhong Q, Minoo P, Li C, Ann DK, Frenkel B, Morrisey EE,
Crandall ED, Borok Z (2008) Foxp2 inhibits Nkx2.1-mediated
transcription of SP-C via interactions with the Nkx2.1 homeo-
domain. Am J Respir Cell Mol Biol 38:750–758
Zilina O, Reimand T, Zjablovskaja P, Mannik K, Mannamaa M, Traat
A, Puusepp-Benazzouz H, Kurg A, Ounap K (2011) Maternally
and paternally inherited deletion of 7q31 involving the FOXP2
gene in two families. Am J Med Genet A
Zweier C, de Jong EK, Zweier M, Orrico A, Ousager LB, Collins AL,
Bijlsma EK, Oortveld MA, Ekici AB, Reis A, Schenck A, Rauch
A (2009) CNTNAP2 and NRXN1 are mutated in autosomal-
recessive Pitt-Hopkins-like mental retardation and determine the
level of a common synaptic protein in Drosophila. Am J Hum
Genet 85:655–666
1698 Hum Genet (2012) 131:1687–1698
123
